Literature DB >> 25628279

A cemented acetabular component with a reinforcement cross provides excellent medium-term fixation in total hip arthroplasty after pelvic irradiation.

A Felden1, G Vaz2, S Kreps3, P Anract1, M Hamadouche1, D J Biau1.   

Abstract

Conventional cemented acetabular components are reported to have a high rate of failure when implanted into previously irradiated bone. We recommend the use of a cemented reconstruction with the addition of an acetabular reinforcement cross to improve fixation. We reviewed a cohort of 45 patients (49 hips) who had undergone irradiation of the pelvis and a cemented total hip arthroplasty (THA) with an acetabular reinforcement cross. All hips had received a minimum dose of 30 Gray (Gy) to treat a primary nearby tumour or metastasis. The median dose of radiation was 50 Gy (Q1 to Q3: 45 to 60; mean: 49.57, 32 to 72). The mean follow-up after THA was 51 months (17 to 137). The cumulative probability of revision of the acetabular component for a mechanical reason was 0% (0 to 0%) at 24 months, 2.9% (0.2 to 13.3%) at 60 months and 2.9% (0.2% to 13.3%) at 120 months, respectively. One hip was revised for mechanical failure and three for infection. Cemented acetabular components with a reinforcement cross provide good medium-term fixation after pelvic irradiation. These patients are at a higher risk of developing infection of their THA. ©2015 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Acetabular reinforcement; Cemented; Hip; Pelvic irradiation; Radiation osteitis; Replacement

Mesh:

Year:  2015        PMID: 25628279     DOI: 10.1302/0301-620X.97B2.34545

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  8 in total

1.  Systematic review of the outcome of cemented versus uncemented total hip arthroplasty following pelvic irradiation.

Authors:  S Walters; A Prasad; B Guevel; K M Sarraf; P Achan; S Dawson-Bowling; S Millington; S A Hanna
Journal:  Musculoskelet Surg       Date:  2019-04-01

2.  A rare presentation of haematuria: hip prosthesis in the bladder.

Authors:  Yih Chyn Phan; Nnaemeka Eli; Praveen Pillai; Jonathan O'Dair
Journal:  BMJ Case Rep       Date:  2018-03-22

Review 3.  Acetabular fixation in total hip arthroplasty in the previously irradiated pelvis: a review of basic science and clinical outcomes.

Authors:  John Patrick Connors; Patrick Garvin; Jacob Silver; Adam Lindsay; Olga Solovyova
Journal:  Arch Orthop Trauma Surg       Date:  2022-08-19       Impact factor: 2.928

4.  Resection arthroplasty in radiation-induced osteonecrosis of the hip.

Authors:  Hyung Suk Kang; Taehun Kim; So Hak Chung
Journal:  J Clin Orthop Trauma       Date:  2018-02-24

5.  UNCEMENTED ARTHROPLASTY AFTER HIP METASTATIC DISEASE AND MULTIPLE MYELOMA.

Authors:  André Mathias Baptista; Sergio Pinheiro de Souza Meirelles; Daniel César Seguel Rebolledo; Luiz Filipe Marques Correia; Olavo Pires de Camargo
Journal:  Acta Ortop Bras       Date:  2016 Jul-Aug       Impact factor: 0.513

6.  Differential proteomic screening and identification for non-traumatic necrotic femoral osseous tissue.

Authors:  Peng Yan; Yeping Zhu; Hui Zhao; Yanyan Lu; Yuzhong Gao
Journal:  Exp Ther Med       Date:  2017-04-12       Impact factor: 2.447

7.  Total hip arthroplasty with reconstruction of acetabulum through direct anterior approach for metastatic bone disease of acetabulum combined with pathological proximal femoral neck fracture: A case report.

Authors:  Hironori Ochi; Tatsuya Takagi; Tomonori Baba; Masahiko Nozawa; Sung-Gon Kim; Yuko Sakamoto; Suguru Kato; Yasuhiro Homma; Kazuo Kaneko; Muneaki Ishijima
Journal:  Trauma Case Rep       Date:  2021-02-26

8.  Functional and Survival Outcomes of Patients following the Harrington Procedure for Complex Acetabular Metastatic Lesions.

Authors:  Andrea Plaud; Jean Gaillard; François Gouin; Aurélie Le Thuaut; Peggy Ageneau; Juliane Berchoud; Alban Fouasson-Chailloux; Vincent Crenn
Journal:  Curr Oncol       Date:  2022-08-19       Impact factor: 3.109

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.